China Economic Momentum Stays Weak as Consumption Falters

Watch on YouTube ↗  |  September 15, 2026 at 05:10  |  1:32:18  |  Bloomberg Markets
Speakers
Yvonne Man — Head of APAC, CoinDesk
Zhou Zhike — Assistant President, China State Construction International
Yanliang Miao — CICC Chief Economist and former China State Administration of Foreign Exchange (SAFE) official
David Savage — Editor, The Block
Mark Cranfield — Cross Asset Strategist, Bloomberg
Hyosung — Korea Economist, Bloomberg Economics
Winnie Hsu — Bloomberg Reporter (Asia Markets)
David Ingles — Anchor, Bloomberg
Linda — China Auto Reporter, Bloomberg
Julia Fioretti — Asia Equity Capital Markets Reporter, Bloomberg
Samantha Altman — Bloomberg Artificial Intelligence and Venture Capital editor
Avril Hong — Reporter, Bloomberg Markets

Summary

Bloomberg's The China Show focused on weak Chinese August activity data, with retail sales and property missing while industrial production beat, alongside policy signals from China's electronics five-year plan and Hong Kong's Northern Metropolis plan. The show also covered the global AI safety debate, CICC's view that AI is China's new growth engine and limits renminbi appreciation, and bond-market anxiety as the US 10-year yield touched 5%. Later segments discussed resilient Korea/Taiwan chip demand, Chinese biotech as an AI trade, and GAC's consolidation with FAW.

  • China August data was mixed: retail sales weak, industrial production strong, and property still contracting.
  • Beijing released a five-year electronics plan targeting advanced AI, memory chips, and 30 trillion yuan revenue by 2030.
  • US-China AI safety rhetoric clashed amid Trump comments and Chinese foreign ministry pushback.
  • Hong Kong's first five-year plan and Northern Metropolis project were previewed.
  • CICC's Yanliang Miao discussed AI as China's new growth engine and lowered renminbi appreciation ceiling.
  • Bond investors watched 20-year auctions and US 10-year yields near 5%.
  • Bloomberg Economics said Korea-Taiwan chip production remains supply-constrained despite AI slowdown fears.
  • Chinese biotech outperformed on AI drug discovery, and GAC shares rose on FAW deal news.
Ideas
Mark Cranfield Cross Asset Strategist, Bloomberg 13:23
20-year auctions pose bond-market event risk.
Cranfield warns the 20-year sector is unpopular and auction-prone; a sloppy 20-year JGB auction could trigger broader bond-market stress, while a smooth one would help the US 20-year auction later. He sees cross-asset implications and says a bad result could cause everything to implode.
Mark Cranfield Cross Asset Strategist, Bloomberg 14:07
JGB long-end yields falling on demand.
Cranfield says long-end JGB yields are at levels where demand is emerging for 30-year and off-the-run 40-year bonds, and the long end is coming down, with similar dynamics seen in the US.
Yvonne Man Head of APAC, CoinDesk 23:27
China chip plan supports domestic semiconductors.
China's five-year plan for electronics targets advanced edge AI, high-end memory chips, and chip design, aiming for 30 trillion yuan in electronics revenue by 2030. Yvonne frames this policy support as a bright spot for the economy and notes chip stocks and domestic AI benchmarks are drawing interest despite US-China AI tensions.
Zhou Zhike Assistant President, China State Construction International 28:14
Northern Metropolis drives CSCI construction growth.
The Northern Metropolis is a real multi-decade development program with HK$5-7 trillion of potential investment. Zhou says China State Construction International has been positioning since 2021, has won tens of billions in waste-management contracts, has 47 years of Hong Kong experience with 97% local employees, and uses modular integrated construction that can cut construction periods and protect margins/IR.
Yanliang Miao CICC Chief Economist and former China State Administration of Foreign Exchange (SAFE) official 48:54
AI is China's new growth engine.
Miao argues China's old property-led model is giving way to an AI- and productivity-driven growth engine. AI accounted for 45% of Chinese export growth in the first eight months, and China has three advantages: broad adoption, cost-efficient open-source models, and infrastructure/energy capacity; AI is also capital-intensive, supporting data centers, cooling, and energy investment.
Yanliang Miao CICC Chief Economist and former China State Administration of Foreign Exchange (SAFE) official 57:53
AI curbs renminbi appreciation ceiling.
Miao had called for a stronger renminbi but now sees a lower ceiling for appreciation because AI is spreading in nontradable services such as health care, education, and delivery, which adds deflationary pressure and reverses the usual productivity-led appreciation dynamic.
David Ingles Anchor, Bloomberg 67:23
AI safety framework lifts China cybersecurity.
David notes Chinese cybersecurity stocks are extending large gains after the regulator released a new AI safety governance framework, and markets are treating AI safety/security as a tactical opportunity worth tracking.
David Savage Editor, The Block 71:52
Treasury yields risk further repricing higher.
Savage says Treasuries are not yet attractive despite high nominal yields because the market is focused on inflation and oil rather than growth. He warns the US term premium is below the start of the year and fiscal/credibility risks are not priced; a 50bp repricing could push the 10-year yield to 5.5%-6%.
Hyosung Korea Economist, Bloomberg Economics 73:47
AI supply crunch supports Korea-Taiwan chips.
Hyosung argues AI chips, HBM, and advanced packaging remain in short supply, so near-term production in Korea and Taiwan is supply-constrained rather than demand-constrained. Demand is broadening from training to inference, and data-center investment has multi-year lead times, so an AI development slowdown would mainly cut new investment rather than current demand; total investment cutbacks, not delays, are the key downside risk.
Winnie Hsu Bloomberg Reporter (Asia Markets) 83:15
AI drug discovery boosts Chinese biotech.
Winnie says Chinese biotech is outperforming because of strong earnings, cheaper valuations than US peers, and AI-driven drug discovery that can cut development time from about 4.5 years to 12-18 months and boost licensing/royalty income. Risks include a high bar after the sector's 65% rally, small sector size, competition from CROs/big pharma, and weaker AI sentiment.
Linda China Auto Reporter, Bloomberg 87:52
GAC-FAW deal aids auto consolidation.
Linda explains FAW will become GAC's second-largest shareholder through a joint asset deal involving overseas-listed JV capacity, laying groundwork for combining two state-owned carmakers. She sees consolidation as a positive first step toward solving industry overcapacity, but execution depends on central-government pressure and entrenched SOE interests.
Up Next

This Bloomberg Markets video, published September 15, 2026, features Mark Cranfield, Yvonne Man, Zhou Zhike, Yanliang Miao, David Ingles, David Savage, Hyosung, Winnie Hsu, Linda discussing Japanese 20-year government bonds, TLT, Japanese long-term government bonds, China semiconductors, 3311.HK, CQQQ, USD/CNH, China cybersecurity stocks, US10Y, SMH, EWY, EWT, Hang Seng Biotech Index, 2238.HK. 11 trade ideas extracted by AI with direction and confidence scoring.

Speakers: Mark Cranfield, Yvonne Man, Zhou Zhike, Yanliang Miao, David Ingles, David Savage, Hyosung, Winnie Hsu, Linda  · Tickers: Japanese 20-year government bonds, TLT, Japanese long-term government bonds, China semiconductors, 3311.HK, CQQQ, USD/CNH, China cybersecurity stocks, US10Y, SMH, EWY, EWT, Hang Seng Biotech Index, 2238.HK